Thermalin Inc. — Department of Defense STTR Phase I: ST18C-004
Thermalin Inc. — STTR Phase I award from Department of Defense.
- Amount
- $224,124
- Agency
- Department of Defense · Defense Advanced Research Projects Agency
- Program / Phase
- STTR · Phase I
- Topic
- ST18C-004
- Solicitation
- 18.C
- NAICS
- —
- Place of performance
- MA
- Period
- 2019-03-25 → 2020-01-24
Description
StampPump is a postage-stamp-sized (27x27x6 mm), fully-self-contained, closed-loop insulin patch pump system that is filled at the factory with enough insulin to treat a person with T1- or trauma-induced hyperglycemia for a full week. The device is shelf stable for at least 90 days and so is compatible with critical-care or forward deployment use. We propose to augment this system with the ability to control delivery of counter-regulatory medications -- either glucagon or dextrose -- so that it can automatically mitigate hyperglycemia while reducing the risk of hypoglycemia. The augmented system would be designed for simple deployment by critical care nurses or even field medics.